FDA approves first generic nasal spray to treat opioid overdose  

On Friday, the FDA approved the first generic of the opioid overdose-reversing drug, Narcan, the life-saving nasal spray that currently sells in packs of two for between $130 and $150.

Source: the Mail online | Health - April 24, 2019 Category: Consumer Health News Source Type: news